Sarepta Therapeutics said on Tuesday that a 16-year-old boy died from acute liver failure months after receiving the company's U.S-approved gene therapy for a rare muscular dystrophy. The patient ...

CHO Plus, Inc. ( a leading developer of biopharmaceutical manufacturing technology, announced that U.S. Patent No. 12,252,713 was issued by the United States Patent and Trademark Office. The patent ...

The axolotl (Ambystoma mexicanum) has extraordinary regenerative abilities—the salamander can regrow lost limbs and repair ...

The global viral vectors for non-human primates market was valued at USD 145.8 Mn in 2023 and is projected to grow at a CAGR ...

NewBiologix, a technology innovation company pioneering efficient, cost-effective, and scalable production of viral vectors for gene and cell therapy, today released a scientific white paper outlining ...

The axolotl is a powerful model for understanding regeneration, however, studying the axolotl’s nervous system has been ...

One patient with Duchenne muscular dystrophy (DMD) has passed away following treatment with Sarepta Therapeutics’ gene therapy Elevidys, the biotech ...

Full Circles Therapeutics, a leader in next-generation genome engineering, announces that the United States Patent and Trademark Office (USPTO) has allowed its foundational patent titled "TARGETED ...

After Repligen (RGEN) announced that it has purchased 908 Devices’ (MASS) desktop portfolio of four devices for bioprocessing process ...